Please login to the form below

Not currently logged in
Email:
Password:

Meet the Judges


The PMEA judging panel comprises a range of experts with a breadth of knowledge and experience, from pharmaceutical marketing specialists to leading management consultants to top business school academics.

Richard Bartlett

Richard Bartlett is an associate partner at McKinsey & Company in London and a leader in McKinsey’s Healthcare and Health Systems practice, and Medical Products practice. Richard serves clients across both the public and private sector across Europe and the Middle East on a broad range of topics.

Previously, Richard was the co-Founder and Deputy Director of ‘Innovations in Healthcare’ (formerly known as the International Partnership for Innovative Healthcare Delivery), a non-profit established by McKinsey, the World Economic Forum and Duke University.

Richard has supported the preparation of a number of landmark health systems reports. Including in 2009, “Unlocking Productivity: Lessons from Entrepreneurs Around the World” that was presented at Davos. In 2012, he co-authored “A Neglected Resource: Transforming Healthcare through Human Capital” which was presented at the Global Health Policy Summit in London. Richard has authored various other reports and case studies on healthcare innovation.

Richard holds a first class degree from the University of Warwick in Industrial Economics where he was the deputy coordinator of the Warwick Economics Summit in 2008, the largest student-run conference in Europe.

Linda Cowie

Linda Cowie, Director Patient Experience, Patient-ly part of the Bionical Group.  Linda has over 25 years’ international director level experience in healthcare marketing and communications spanning both client and agency side. Passionate about facilitating patient engagement and empowerment, Linda has specialised in this area over the past 15 years. Her focus has been on identifying and addressing the challenges associated with facilitating delivery of behaviour change through effective healthcare information and communication.

Her consultancy in this area is built from both commercial experience and independent academic research via an MPhil  completed in 2012. Linda is also an Advisory Board member for the Patient Information Forum (PiF) and has presented at several conferences and workshops’.

Deborah Evans

Deborah Evans FFRPS FRPharmS FRSPH is managing director of Pharmacy Complete (The Tipping Point Ltd), whose purpose is to help patients to live well for longer by enabling pharmacy to have a healthier future. In pharmacy, our professional credibility, understanding of medicines access, health policy and our extensive professional network ensures that we can engage with the right people, have the conversations that matter and develop solutions that work. We help pharmacy be more successful by supporting business sustainability, training for the pharmacy team, project management, service design and implementation and much more. Deborah led the national, award-winning Healthy Living Pharmacy (HLP) pathfinder work programme on behalf of the national pharmacy bodies and the Department of Health, initially project managing the acclaimed Portsmouth HLP pilot and now offers a complete suite of services and resources to enable pharmacy teams to make a difference to the health and wellbeing of their local population. She is passionate about enabling more women to take senior positions in the pharmacy profession and is founder of the highly successful Women in Pharmacy Facebook community which has 7000 members across the world.

Her professional achievements include being made a Fellow of the Royal Pharmaceutical Society (RPS), serving the RPS English Pharmacy Board, and becoming a Faculty Fellow. She is also visiting senior lecturer at King’s College, London. Deborah feels it is important to keep her pharmacy knowledge up to date and feet firmly planted in the real world so still works regularly in community pharmacy within a GP practice.

Karen Fraser

Karen Fraser is managing director of Acuitas, a consultancy providing astute commercial insight and international KOL perspective to the biopharma and investment communities. She has over 30 years' industry experience, which includes senior sales and marketing positions in companies such as Amersham International, Glaxo Laboratories and Lorex Synthélabo. Karen also set up a successful marketing consultancy specialising in the provision of commercial planning and implementation for companies wishing to enter the UK market. Prior to setting up Acuitas, she spent 15 years as vice president at Quintiles, providing marketing and therapeutic insight to support global Due Diligence and Business Development activities.

Stephanie Hall

Stephanie Hall is managing director of Uptake Strategies, an award winning healthcare marketing consultancy specialising in brand planning, strategy and launch with a mission to inspire excellence and innovation in healthcare marketing leading to measurable business impact and more capable, motivated teams.  Stephanie works across the US, Europe, Latin-America and Asia with large and small healthcare companies across pharma, biotech and consumer healthcare. Before founding Uptake Strategies, Stephanie worked in the pharmaceutical industry for over 20 years across a number of roles across marketing, finance and sales at GSK, Eli Lilly & Co and Sanofi. Stephanie is a Chartered Management Accountant and Chartered Marketer. She has been a post-graduate lecturer at the Chartered Institute of Marketing (CIM) and also speaks several European languages. Stephanie speaks and publishes across the industry on brand planning, customer experience and launch excellence, having worked on 100 healthcare launches in the past ten years.

Alasdair Mackintosh

Alasdair Mackintosh is Director and Founder, Keyhaven Associates Ltd.He is a senior business advisor and independent strategy and transformation consultant with extensive experience in the healthcare sector. He is also a Trustee and Vice Chair of the Pituitary Foundation, a patient-focused charity which provides essential information and support for people diagnosed with a range of pituitary disorders.

Over the past 24 years, Alasdair has supported many major healthcare organisations to enhance their commercial performance, develop effective digital strategies, and deliver better health outcomes for patients. He also helps entrepreneurs and investors in smaller, emerging enterprises to assess expansion opportunities, strengthen their business processes and governance, and to build effective organisations.

Alasdair was previously a partner and member of the global leadership teams at PA, Eden McCallum, Archstone and Gemini Consulting. He has an MSc in Business Management from the University of London and is a Sloan Fellow of the London Business School.

Daniel Mathews

Daniel Mathews is the head of EY’s Advisory Markets. His passion lies in the pharmaceutical industry where he has over 20 years of transformation experience working across the USA, Asia and Europe. Throughout his career, Daniel has focused on delivering novel and effective marketing programmes particularly focusing on patient services and health outcome programmes to drive growth. Daniel is currently leading the development of EY’s “Outcome Services” to enable both Life Science Companies and Health Providers to deliver patient value.

Eamon O'Brien

Eamon O'Brien is Managing Director of the CR&C Organisation. As part of his coaching and leadership development portfolio, Eamon has created the Squad Mentality Programme that unites teams behind the philosophy and strategy of the business so that they are engaged, perform and deliver.

Jo Pisani

Jo Pisani is a partner leading the UK Pharma and Lifesciences Consulting Practice at PwC Strategy&. She has thirteen years of industry experience in the pharmaceuticals, energy, petrochemicals, and fast-moving consumer goods industries with BP and SmithKline Beecham where she held positions in the engineering, operations, IT, and commercial functions. Before joining PwC, she spent three years with Booz&Co, a strategic management consultancy where she focused on strategic issues in the pharmaceuticals and energy sectors. Jo assists clients developing strategy, supporting deals and conducting valuations. Her clients include Big Pharma, biotech, generics, OTC, contract manufacturers, contract research organisations, ministries of health, private equity and banks. She is a key author on PwC’s Pharma2020 thought leadership series.

Rachael Scott

Rachael Scott is a partner leading the UK Lifesciences Practice at PA Consulting.  Rachael started her career within industry and has over 16 years’ experience working with LifeSciences organisations.  Rachael specialises in operational and commercial improvement, leading cross functional programmes in both Biotech and large Pharma with a focus on what it really takes to make change stick . She has a passion for working with organisations that look to challenge their selves and face the disruption in the market place head on.

Paul Simpson

Paul Simpson is the Head of Commercial Operations UK and European Key Accounts at IQVIA.

Paul has extensive pan-European & US experience of pharma/biotech commercialisation and has held senior roles in marketing, sales and general management.

He is a staunch advocate of account management, using environmental understanding to derive practical solutions to help clients drive healthcare forward and ultimately lead to better outcomes for patients.

Professor Brian D Smith

Professor Brian D Smith is an academic, author and advisor who has worked in the industry since 1978. He researches the evolution of the life sciences industry at both Bocconi and Hertfordshire Universities and has published 300 papers, books and articles about strategy in the industry, including The Future of Pharma, Darwin’s Medicine and, most recently, Brand Therapy. As Principal Advisor of Pragmedic Limited, he advises many of the industry’s leading companies about how to adapt competitive capabilities to changing market conditions.

Dr Paul Stuart-Kregor

Dr Paul Stuart-Kregor is one of the three founders of The CELLO Health Consultancy and has worked in pharmaceuticals for 30 years, both client side and consultancy.
Paul has wide-ranging pharmaceutical, OTC and consumer marketing experience in UK and overseas, with expertise focused in the areas of market scoping and market insight for new and existing therapy areas, marketing strategy (Phase II to in-market compounds), brand development/repositioning, organisational design and process development plus marketing and operational excellence.
He holds an MA from Cambridge University and a PhD in Reproductive Endocrinology . He has been extensively published across a range of industry journals.

Michael Thomas

Michael Thomas, partner, Pharmaceutical & Healthcare Team, A. T. Kearney. Michael is a member of A. T. Kearney’s global pharmaceutical and healthcare practice and leads the UK pharmaceutical team. He has consulted for over fifteen years in the pharmaceutical industry, helping pharmaceutical and biopharmaceutical clients formulate strategic responses to changes in the healthcare environment, regularly working with senior management teams. His current area of interest is in examining the opportunities that the pharmaceutical industry has to partner with healthcare providers to improve access and returns on the new generation of specialist / biotech products, both in developed and emerging markets. He has contributed to many industry articles and is frequent conference speaker.
Before joining A.T. Kearney, Michael was EMEA leader for Sales & Marketing in the pharmaceutical practices of IBM and PwC Consulting. He has held a senior management position in Strategy and Planning with SmithklineBeecham, and before entering consultancy ran a PR agency specialising in lifestyle products.

Sponsors